Condition: CADASIL · Cerebral Autosomal Dominant Arteriopatie With Subcortical Infarcts and Leukoencephalopathy · Sponsor: Jeju National University Hospital
K-CADASIL is a 10-year prospective study of 500 Korean patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a genetic brain disease that causes stroke and dementia. The investigators will track symptoms, brain scans, memory tests, and gene information to understand disease progression in Koreans and identify better treatments. Participants will visit clinics regularly for check-ups and blood tests. This study aims to help improve care for CADASIL patients and families worldwide.
This description comes directly from the study's public registry record.
Jay Chol Professor Choi, MD, PhD, MD, PhD · +82-64-754-8160 · jaychoi@jejunu.ac.kr
Always discuss trial participation with your own doctor first.
| Jeju National University Hospital | Jeju City, Jeju-do, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07497867